

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.73367526 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.71426028 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69686041 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64627021 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.43094215 |
| 6 | myeloid dendritic cell differentiation (GO:0043011) | 4.16240128 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02535321 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.02535321 |
| 9 | response to muramyl dipeptide (GO:0032495) | 4.00510359 |
| 10 | * regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.98821380 |
| 11 | myeloid dendritic cell activation (GO:0001773) | 3.98452883 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 3.95395919 |
| 13 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.93954748 |
| 14 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.91647472 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.82991990 |
| 16 | cellular response to ethanol (GO:0071361) | 3.82435327 |
| 17 | negative thymic T cell selection (GO:0045060) | 3.80138229 |
| 18 | positive regulation of interleukin-2 production (GO:0032743) | 3.77019712 |
| 19 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.70738774 |
| 20 | regulation of activation of Janus kinase activity (GO:0010533) | 3.70253330 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66354855 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.66354855 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66354855 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66354855 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66354855 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.66354855 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62767039 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.62678173 |
| 29 | negative T cell selection (GO:0043383) | 3.62427151 |
| 30 | neutrophil activation (GO:0042119) | 3.62270260 |
| 31 | defense response to protozoan (GO:0042832) | 3.61299963 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.61152880 |
| 33 | * positive regulation of interleukin-12 production (GO:0032735) | 3.60836544 |
| 34 | granulocyte activation (GO:0036230) | 3.59238368 |
| 35 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.56276748 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.53904120 |
| 37 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.50793625 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.49328022 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47740883 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45249456 |
| 41 | histone H3-K4 trimethylation (GO:0080182) | 3.45140410 |
| 42 | positive regulation of humoral immune response (GO:0002922) | 3.45096623 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43719889 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.43642563 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.40959995 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38327704 |
| 47 | response to peptidoglycan (GO:0032494) | 3.34955716 |
| 48 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.33481070 |
| 49 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.31957926 |
| 50 | positive regulation of interleukin-10 production (GO:0032733) | 3.31832793 |
| 51 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30300991 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.29087973 |
| 53 | positive regulation of type 2 immune response (GO:0002830) | 3.28535651 |
| 54 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.27927306 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27796357 |
| 56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.26597225 |
| 57 | leukocyte aggregation (GO:0070486) | 3.25335174 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.25149564 |
| 59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24324900 |
| 60 | positive regulation of developmental pigmentation (GO:0048087) | 3.24242750 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.24129179 |
| 62 | response to protozoan (GO:0001562) | 3.24001930 |
| 63 | response to type I interferon (GO:0034340) | 3.23566175 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.22591755 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.22591755 |
| 66 | positive regulation of interleukin-17 production (GO:0032740) | 3.21593203 |
| 67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20878278 |
| 68 | negative regulation of cell killing (GO:0031342) | 3.20878278 |
| 69 | regulation of RIG-I signaling pathway (GO:0039535) | 3.20693063 |
| 70 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.18168051 |
| 71 | tolerance induction (GO:0002507) | 3.17924825 |
| 72 | response to interleukin-15 (GO:0070672) | 3.17125072 |
| 73 | dendritic cell differentiation (GO:0097028) | 3.16869625 |
| 74 | regulation of immunoglobulin secretion (GO:0051023) | 3.16430280 |
| 75 | positive regulation of B cell differentiation (GO:0045579) | 3.16429423 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16122082 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.15578009 |
| 78 | positive regulation of T cell cytokine production (GO:0002726) | 3.14665179 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 3.14603211 |
| 80 | * regulation of interleukin-12 production (GO:0032655) | 3.14599943 |
| 81 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.13691588 |
| 82 | T cell migration (GO:0072678) | 3.13445055 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12967037 |
| 84 | thymic T cell selection (GO:0045061) | 3.12449126 |
| 85 | positive regulation of defense response to virus by host (GO:0002230) | 3.10932487 |
| 86 | interferon-gamma production (GO:0032609) | 3.10834125 |
| 87 | positive regulation of isotype switching (GO:0045830) | 3.10743585 |
| 88 | regulation of T-helper cell differentiation (GO:0045622) | 3.09620482 |
| 89 | regulation of chronic inflammatory response (GO:0002676) | 3.09085728 |
| 90 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.08213687 |
| 91 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.08185983 |
| 92 | T-helper cell differentiation (GO:0042093) | 3.06874057 |
| 93 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.06874057 |
| 94 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.05862106 |
| 95 | germinal center formation (GO:0002467) | 3.05411415 |
| 96 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.05315375 |
| 97 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.02156875 |
| 98 | mature B cell differentiation (GO:0002335) | 3.01784939 |
| 99 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.01023971 |
| 100 | natural killer cell mediated immunity (GO:0002228) | 3.01023971 |
| 101 | regulation of hypersensitivity (GO:0002883) | 3.00946960 |
| 102 | positive T cell selection (GO:0043368) | 3.00451264 |
| 103 | cellular extravasation (GO:0045123) | 2.99817937 |
| 104 | cellular response to zinc ion (GO:0071294) | 2.97683278 |
| 105 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96908963 |
| 106 | T cell selection (GO:0045058) | 2.96839363 |
| 107 | cellular response to exogenous dsRNA (GO:0071360) | 2.96805743 |
| 108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96770048 |
| 109 | B cell receptor signaling pathway (GO:0050853) | 2.96436369 |
| 110 | interkinetic nuclear migration (GO:0022027) | 2.94956150 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.94210446 |
| 112 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.92576943 |
| 113 | positive regulation of B cell mediated immunity (GO:0002714) | 2.92576943 |
| 114 | macrophage activation involved in immune response (GO:0002281) | 2.90322475 |
| 115 | protein K48-linked deubiquitination (GO:0071108) | 2.89991849 |
| 116 | regulation of B cell proliferation (GO:0030888) | 2.89065763 |
| 117 | positive regulation of heat generation (GO:0031652) | 2.88119212 |
| 118 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.87118360 |
| 119 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84519685 |
| 120 | regulation of pigment cell differentiation (GO:0050932) | 2.82039839 |
| 121 | microglial cell activation (GO:0001774) | 2.80551805 |
| 122 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79971171 |
| 123 | negative regulation of adaptive immune response (GO:0002820) | 2.79957404 |
| 124 | indole-containing compound catabolic process (GO:0042436) | 2.76332165 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.76332165 |
| 126 | tryptophan catabolic process (GO:0006569) | 2.76332165 |
| 127 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76257497 |
| 128 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.75278843 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75066851 |
| 130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75066851 |
| 131 | T cell differentiation involved in immune response (GO:0002292) | 2.73855291 |
| 132 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.73855291 |
| 133 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.73855291 |
| 134 | alpha-beta T cell differentiation (GO:0046632) | 2.73358851 |
| 135 | establishment of protein localization to Golgi (GO:0072600) | 2.73207937 |
| 136 | B cell proliferation (GO:0042100) | 2.73072965 |
| 137 | positive regulation of B cell proliferation (GO:0030890) | 2.70450185 |
| 138 | regulation of germinal center formation (GO:0002634) | 2.67790058 |
| 139 | B cell homeostasis (GO:0001782) | 2.67548122 |
| 140 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.66590007 |
| 141 | regulation of establishment of cell polarity (GO:2000114) | 2.65899272 |
| 142 | hepatocyte apoptotic process (GO:0097284) | 2.65503987 |
| 143 | activated T cell proliferation (GO:0050798) | 2.65195765 |
| 144 | alpha-beta T cell activation (GO:0046631) | 2.64143828 |
| 145 | protein K63-linked deubiquitination (GO:0070536) | 2.63660099 |
| 146 | negative regulation of B cell proliferation (GO:0030889) | 2.61763720 |
| 147 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.61741162 |
| 148 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.61622837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.73631293 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.47426415 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.33134800 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.85623366 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.50759583 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.20399434 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.97668005 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.77131522 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.75842144 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.55609102 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.41813586 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.17485977 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15492935 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14696940 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.96364986 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85847779 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85483044 |
| 18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83199793 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65595087 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61697311 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.53050659 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.43659416 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38374301 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.10800620 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.01822049 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.01080613 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96793117 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90629888 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88773220 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88220014 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87148176 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86127466 |
| 33 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83642564 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79434136 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78608243 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71480466 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68327545 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.66435370 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.63124375 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61491979 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59829724 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57215834 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57116015 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55205482 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53746641 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52063785 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50627130 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50290345 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45809669 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45763457 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45735839 |
| 52 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45695648 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45680729 |
| 54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41599611 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35690724 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35552603 |
| 57 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35375103 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35092416 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35039215 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34860374 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34635773 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34093961 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33908331 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33908331 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31214067 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31192293 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28991633 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28458728 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28130457 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27861727 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25674951 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24648308 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24480446 |
| 74 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23978601 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23356341 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20783780 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18739138 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17444737 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16924578 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16898749 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15565573 |
| 82 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15352319 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.14684271 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13336098 |
| 85 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10763521 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10709189 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10304214 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06717470 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05277744 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04774625 |
| 91 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03999344 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02792787 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02420442 |
| 94 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02116128 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02004257 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01822744 |
| 97 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01419419 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00593083 |
| 99 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00232221 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00032071 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99927807 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99534221 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98790640 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97753161 |
| 105 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97724145 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96902709 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96902709 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96769457 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96728084 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96728084 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95809224 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94587971 |
| 113 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93844256 |
| 114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93055532 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92687775 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92664481 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92489086 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92184075 |
| 119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91500158 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90782499 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90647346 |
| 122 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90460298 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89128310 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88815369 |
| 125 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87506562 |
| 126 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86862433 |
| 127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86612839 |
| 128 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85923669 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85435079 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85316491 |
| 131 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84175528 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83881749 |
| 133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82242088 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80585865 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78207785 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77519207 |
| 137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75868639 |
| 138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75682572 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72582183 |
| 140 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69447762 |
| 141 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67750819 |
| 142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66067981 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65697240 |
| 144 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65297635 |
| 145 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64183906 |
| 146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63908292 |
| 147 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63147456 |
| 148 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.62723205 |
| 149 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.61246304 |
| 150 | CJUN_26792858_Chip-Seq_BT549_Human | 0.60726775 |
| 151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59139788 |
| 152 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57757465 |
| 153 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.54690538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.01743415 |
| 2 | MP0000685_abnormal_immune_system | 3.56969089 |
| 3 | MP0005671_abnormal_response_to | 3.53723965 |
| 4 | MP0001790_abnormal_immune_system | 3.48862993 |
| 5 | MP0005387_immune_system_phenotype | 3.48862993 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.41089755 |
| 7 | MP0003436_decreased_susceptibility_to | 3.37811433 |
| 8 | MP0009785_altered_susceptibility_to | 3.36125042 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.26423499 |
| 10 | MP0001800_abnormal_humoral_immune | 3.24477386 |
| 11 | MP0003303_peritoneal_inflammation | 3.20778152 |
| 12 | MP0004510_myositis | 2.94396815 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.92460446 |
| 14 | * MP0002723_abnormal_immune_serum | 2.80795655 |
| 15 | MP0002419_abnormal_innate_immunity | 2.67749521 |
| 16 | * MP0005025_abnormal_response_to | 2.67690486 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.67063617 |
| 18 | MP0001853_heart_inflammation | 2.58826721 |
| 19 | * MP0001819_abnormal_immune_cell | 2.54224381 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.52919638 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.33195857 |
| 22 | MP0003195_calcinosis | 2.31187492 |
| 23 | MP0002006_tumorigenesis | 2.29540706 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.27930016 |
| 25 | MP0006082_CNS_inflammation | 2.26752904 |
| 26 | MP0002405_respiratory_system_inflammati | 2.23953600 |
| 27 | MP0003724_increased_susceptibility_to | 2.15787902 |
| 28 | MP0004947_skin_inflammation | 2.11848543 |
| 29 | MP0002398_abnormal_bone_marrow | 2.04451173 |
| 30 | * MP0000716_abnormal_immune_system | 1.97922935 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.93431756 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.91078489 |
| 33 | MP0005310_abnormal_salivary_gland | 1.87363572 |
| 34 | MP0002254_reproductive_system_inflammat | 1.80822214 |
| 35 | MP0003646_muscle_fatigue | 1.80069925 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.78495357 |
| 37 | MP0001873_stomach_inflammation | 1.77061174 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.65939821 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.64605913 |
| 40 | * MP0000689_abnormal_spleen_morphology | 1.58405059 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.58047007 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.56649225 |
| 43 | MP0002429_abnormal_blood_cell | 1.56435820 |
| 44 | MP0002722_abnormal_immune_system | 1.53985527 |
| 45 | MP0009764_decreased_sensitivity_to | 1.51260078 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.44420298 |
| 47 | MP0003448_altered_tumor_morphology | 1.41440132 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.38698890 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.35419150 |
| 50 | MP0008469_abnormal_protein_level | 1.32974909 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.31459171 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.28450561 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.27219697 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.24355264 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.24355264 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.23761445 |
| 57 | MP0002933_joint_inflammation | 1.20069981 |
| 58 | MP0003866_abnormal_defecation | 1.19454508 |
| 59 | MP0009278_abnormal_bone_marrow | 1.19419779 |
| 60 | MP0002009_preneoplasia | 1.19324287 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.17426159 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.14966452 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.14663083 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.14626300 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.11733953 |
| 66 | MP0000858_altered_metastatic_potential | 1.11608083 |
| 67 | MP0003828_pulmonary_edema | 1.07027777 |
| 68 | MP0001851_eye_inflammation | 1.06354368 |
| 69 | MP0000383_abnormal_hair_follicle | 1.01467087 |
| 70 | MP0002163_abnormal_gland_morphology | 1.01274872 |
| 71 | MP0009115_abnormal_fat_cell | 0.99529453 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.96394956 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.95831540 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.94359079 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.94312869 |
| 76 | MP0003091_abnormal_cell_migration | 0.91664935 |
| 77 | MP0004043_abnormal_pH_regulation | 0.90793329 |
| 78 | MP0003252_abnormal_bile_duct | 0.88964876 |
| 79 | MP0002168_other_aberrant_phenotype | 0.88712582 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.88292618 |
| 81 | MP0000427_abnormal_hair_cycle | 0.86787518 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 0.85286856 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.83957835 |
| 84 | MP0005647_abnormal_sex_gland | 0.83785600 |
| 85 | MP0000343_altered_response_to | 0.83247762 |
| 86 | MP0000604_amyloidosis | 0.82320492 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.81656957 |
| 88 | MP0003045_fibrosis | 0.80239727 |
| 89 | MP0000490_abnormal_crypts_of | 0.79789355 |
| 90 | MP0004130_abnormal_muscle_cell | 0.78980004 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.78728414 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.77427750 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.76239012 |
| 94 | MP0009763_increased_sensitivity_to | 0.75797387 |
| 95 | * MP0008057_abnormal_DNA_replication | 0.75543189 |
| 96 | MP0003075_altered_response_to | 0.74746014 |
| 97 | MP0004883_abnormal_blood_vessel | 0.74212747 |
| 98 | MP0010307_abnormal_tumor_latency | 0.73970821 |
| 99 | MP0000249_abnormal_blood_vessel | 0.73580477 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.72641962 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.71761122 |
| 102 | MP0003787_abnormal_imprinting | 0.70649699 |
| 103 | MP0004742_abnormal_vestibular_system | 0.70643042 |
| 104 | MP0008872_abnormal_physiological_respon | 0.70380446 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.68582316 |
| 106 | * MP0005390_skeleton_phenotype | 0.68574373 |
| 107 | MP0008004_abnormal_stomach_pH | 0.66858172 |
| 108 | MP0005166_decreased_susceptibility_to | 0.66127610 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.64680195 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.64317004 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.64264056 |
| 112 | MP0000627_abnormal_mammary_gland | 0.62840657 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.62544432 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.61763215 |
| 115 | MP0001663_abnormal_digestive_system | 0.60167324 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.59821663 |
| 117 | MP0000371_diluted_coat_color | 0.59641877 |
| 118 | * MP0001216_abnormal_epidermal_layer | 0.59209856 |
| 119 | MP0005448_abnormal_energy_balance | 0.58788427 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.58217298 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.57990520 |
| 122 | MP0004142_abnormal_muscle_tone | 0.57161701 |
| 123 | MP0003795_abnormal_bone_structure | 0.57026837 |
| 124 | MP0001881_abnormal_mammary_gland | 0.56519995 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.56312952 |
| 126 | MP0005164_abnormal_response_to | 0.54775050 |
| 127 | MP0004381_abnormal_hair_follicle | 0.53987262 |
| 128 | MP0002928_abnormal_bile_duct | 0.52085691 |
| 129 | MP0001191_abnormal_skin_condition | 0.51904005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.97508187 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.48393968 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.27116508 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.08504510 |
| 5 | Optic neuritis (HP:0100653) | 5.08504510 |
| 6 | Stomatitis (HP:0010280) | 4.85756144 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.78873615 |
| 8 | Orchitis (HP:0100796) | 4.70846334 |
| 9 | Myositis (HP:0100614) | 4.60094969 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58848996 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.52089759 |
| 12 | Vasculitis (HP:0002633) | 4.23767699 |
| 13 | Genetic anticipation (HP:0003743) | 4.14095709 |
| 14 | Recurrent viral infections (HP:0004429) | 4.10557401 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.01822077 |
| 16 | Recurrent skin infections (HP:0001581) | 3.80699850 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75742342 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75742342 |
| 19 | Pulmonary infiltrates (HP:0002113) | 3.75563185 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74079841 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.56732526 |
| 22 | Arterial thrombosis (HP:0004420) | 3.49103707 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.44753870 |
| 24 | Increased IgM level (HP:0003496) | 3.42751156 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.37931796 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.37394440 |
| 27 | Chronic otitis media (HP:0000389) | 3.36555796 |
| 28 | Meningitis (HP:0001287) | 3.34843040 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.26885605 |
| 30 | Obstructive lung disease (HP:0006536) | 3.24578159 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24578159 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24110008 |
| 33 | T lymphocytopenia (HP:0005403) | 3.16118340 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.15802677 |
| 35 | Gingivitis (HP:0000230) | 3.14534349 |
| 36 | Cellulitis (HP:0100658) | 3.14316659 |
| 37 | Clumsiness (HP:0002312) | 3.13532288 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13447240 |
| 39 | Recurrent bronchitis (HP:0002837) | 3.12766565 |
| 40 | Colitis (HP:0002583) | 3.02745149 |
| 41 | Hemoptysis (HP:0002105) | 3.00964091 |
| 42 | Periodontitis (HP:0000704) | 3.00656817 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 3.00012358 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.93387921 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.91306891 |
| 46 | Leukocytosis (HP:0001974) | 2.91134243 |
| 47 | Stomach cancer (HP:0012126) | 2.89942805 |
| 48 | Myocardial infarction (HP:0001658) | 2.87271273 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.86806484 |
| 50 | Hyperventilation (HP:0002883) | 2.84565873 |
| 51 | Increased cerebral lipofuscin (HP:0011813) | 2.80454797 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.78271094 |
| 53 | Pustule (HP:0200039) | 2.77920559 |
| 54 | Abnormality of T cells (HP:0002843) | 2.76430972 |
| 55 | Protruding tongue (HP:0010808) | 2.76217910 |
| 56 | Chronic diarrhea (HP:0002028) | 2.73449302 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 2.72690089 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.72288197 |
| 59 | Thyroiditis (HP:0100646) | 2.71008893 |
| 60 | Eosinophilia (HP:0001880) | 2.67942219 |
| 61 | IgA deficiency (HP:0002720) | 2.67460428 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.65129719 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.64791774 |
| 64 | Fair hair (HP:0002286) | 2.63886988 |
| 65 | Lymphopenia (HP:0001888) | 2.58294863 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57667732 |
| 67 | Osteomyelitis (HP:0002754) | 2.57357239 |
| 68 | IgG deficiency (HP:0004315) | 2.56846352 |
| 69 | Chest pain (HP:0100749) | 2.53953967 |
| 70 | Encephalitis (HP:0002383) | 2.52661266 |
| 71 | Hematochezia (HP:0002573) | 2.52466989 |
| 72 | Nasal polyposis (HP:0100582) | 2.52219617 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.52204341 |
| 74 | Gingival bleeding (HP:0000225) | 2.51352934 |
| 75 | Gangrene (HP:0100758) | 2.48650443 |
| 76 | IgM deficiency (HP:0002850) | 2.46430573 |
| 77 | Increased IgE level (HP:0003212) | 2.45999799 |
| 78 | Severe combined immunodeficiency (HP:0004430) | 2.45708294 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.44379733 |
| 80 | Thick nail (HP:0001805) | 2.44096360 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.43724299 |
| 82 | Thrombocytosis (HP:0001894) | 2.42832751 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.42058128 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.42009714 |
| 85 | Dysmetric saccades (HP:0000641) | 2.41977001 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.40863036 |
| 87 | Prostate neoplasm (HP:0100787) | 2.40238967 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.38792216 |
| 89 | Widely spaced teeth (HP:0000687) | 2.37996181 |
| 90 | Pancreatic cysts (HP:0001737) | 2.37720001 |
| 91 | Emphysema (HP:0002097) | 2.36602075 |
| 92 | Chronic hepatic failure (HP:0100626) | 2.33038225 |
| 93 | Anhidrosis (HP:0000970) | 2.32698835 |
| 94 | Recurrent sinusitis (HP:0011108) | 2.31893345 |
| 95 | Generalized hypopigmentation of hair (HP:0011358) | 2.31510994 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.30850683 |
| 97 | B lymphocytopenia (HP:0010976) | 2.30108667 |
| 98 | Abnormality of B cell number (HP:0010975) | 2.30108667 |
| 99 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.28501160 |
| 100 | Combined immunodeficiency (HP:0005387) | 2.25227576 |
| 101 | Anorexia (HP:0002039) | 2.24500014 |
| 102 | Granulocytopenia (HP:0001913) | 2.22778001 |
| 103 | Arthralgia (HP:0002829) | 2.20452342 |
| 104 | Amaurosis fugax (HP:0100576) | 2.18575236 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.17343976 |
| 106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15072377 |
| 107 | Osteolytic defects of the hand bones (HP:0009699) | 2.15072377 |
| 108 | Viral hepatitis (HP:0006562) | 2.14355453 |
| 109 | Attenuation of retinal blood vessels (HP:0007843) | 2.14287716 |
| 110 | Joint swelling (HP:0001386) | 2.13762041 |
| 111 | Alveolar cell carcinoma (HP:0006519) | 2.11570459 |
| 112 | Skin ulcer (HP:0200042) | 2.10005232 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.08865798 |
| 114 | Premature loss of primary teeth (HP:0006323) | 2.08061677 |
| 115 | Urticaria (HP:0001025) | 2.04587541 |
| 116 | Restrictive lung disease (HP:0002091) | 2.03260358 |
| 117 | Fatigue (HP:0012378) | 2.02237777 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 2.02171542 |
| 119 | Sepsis (HP:0100806) | 2.00817365 |
| 120 | Pulmonary embolism (HP:0002204) | 1.99868029 |
| 121 | Acute myeloid leukemia (HP:0004808) | 1.99709579 |
| 122 | Congenital stationary night blindness (HP:0007642) | 1.96369974 |
| 123 | Abnormality of the pleura (HP:0002103) | 1.91544957 |
| 124 | Bronchitis (HP:0012387) | 1.90110188 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.86415967 |
| 126 | Abnormality of binocular vision (HP:0011514) | 1.84368698 |
| 127 | Diplopia (HP:0000651) | 1.84368698 |
| 128 | Febrile seizures (HP:0002373) | 1.83488134 |
| 129 | Acute lymphatic leukemia (HP:0006721) | 1.79706017 |
| 130 | Hypoplasia of the thymus (HP:0000778) | 1.77445486 |
| 131 | Lymphoma (HP:0002665) | 1.73924296 |
| 132 | Prominent nose (HP:0000448) | 1.73723397 |
| 133 | Facial diplegia (HP:0001349) | 1.67156969 |
| 134 | Progressive inability to walk (HP:0002505) | 1.66178712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.40194493 |
| 2 | MAP3K14 | 5.47351611 |
| 3 | MAP4K1 | 3.94510528 |
| 4 | TXK | 3.07595272 |
| 5 | TBK1 | 3.00222289 |
| 6 | JAK3 | 2.99969074 |
| 7 | TYK2 | 2.95857288 |
| 8 | * IKBKB | 2.85929130 |
| 9 | IRAK3 | 2.84045650 |
| 10 | RIPK4 | 2.80129379 |
| 11 | IKBKE | 2.77460946 |
| 12 | IRAK4 | 2.65593280 |
| 13 | ACVR1B | 2.39167176 |
| 14 | BLK | 2.34032277 |
| 15 | MAP3K13 | 2.29467604 |
| 16 | JAK1 | 2.22904118 |
| 17 | * CHUK | 2.10859060 |
| 18 | ZAP70 | 1.73976726 |
| 19 | MST4 | 1.67699651 |
| 20 | KIT | 1.66732397 |
| 21 | PIM2 | 1.63262207 |
| 22 | STK10 | 1.62123283 |
| 23 | BMPR1B | 1.59632107 |
| 24 | SIK3 | 1.59418962 |
| 25 | AKT3 | 1.59005768 |
| 26 | SYK | 1.56818088 |
| 27 | CAMK1D | 1.54193278 |
| 28 | ITK | 1.53659257 |
| 29 | ADRBK2 | 1.52192098 |
| 30 | PIM1 | 1.50386158 |
| 31 | TEC | 1.46572894 |
| 32 | BTK | 1.45554435 |
| 33 | FGFR3 | 1.42786042 |
| 34 | CSK | 1.41864227 |
| 35 | TGFBR2 | 1.41847102 |
| 36 | BMPR2 | 1.40293775 |
| 37 | CSF1R | 1.39730900 |
| 38 | PIK3CG | 1.39008299 |
| 39 | HCK | 1.35922242 |
| 40 | FGFR4 | 1.32317989 |
| 41 | EPHB1 | 1.32182962 |
| 42 | EPHA3 | 1.26969311 |
| 43 | LCK | 1.23768278 |
| 44 | SGK2 | 1.21260505 |
| 45 | CDK12 | 1.20084937 |
| 46 | CAMK1G | 1.12846385 |
| 47 | NEK9 | 1.08942753 |
| 48 | RPS6KA4 | 1.08460953 |
| 49 | MAP2K3 | 1.07661475 |
| 50 | NLK | 1.05882682 |
| 51 | PRPF4B | 1.03638068 |
| 52 | LYN | 1.01779521 |
| 53 | JAK2 | 1.01411921 |
| 54 | TAOK3 | 0.99691930 |
| 55 | MARK3 | 0.96220439 |
| 56 | IRAK1 | 0.94390328 |
| 57 | MAP3K3 | 0.94383983 |
| 58 | GRK6 | 0.93503066 |
| 59 | CAMKK2 | 0.93077622 |
| 60 | MKNK2 | 0.92063082 |
| 61 | EIF2AK2 | 0.91726405 |
| 62 | MAP3K10 | 0.86593203 |
| 63 | TNK2 | 0.86514112 |
| 64 | PRKCQ | 0.83859538 |
| 65 | ERN1 | 0.80529315 |
| 66 | STK24 | 0.79729915 |
| 67 | SIK2 | 0.79087523 |
| 68 | WNK1 | 0.78147537 |
| 69 | LRRK2 | 0.77356163 |
| 70 | CDC42BPA | 0.76713668 |
| 71 | MAP3K7 | 0.75459877 |
| 72 | INSRR | 0.73896911 |
| 73 | TGFBR1 | 0.71600400 |
| 74 | SGK3 | 0.71492426 |
| 75 | PRKAA2 | 0.64435892 |
| 76 | MAPK11 | 0.61482489 |
| 77 | CLK1 | 0.61354174 |
| 78 | MAPKAPK2 | 0.60344910 |
| 79 | STK4 | 0.60200425 |
| 80 | DAPK2 | 0.59592211 |
| 81 | TRPM7 | 0.59566888 |
| 82 | NUAK1 | 0.59540453 |
| 83 | ABL1 | 0.59346078 |
| 84 | FES | 0.59277341 |
| 85 | GRK7 | 0.56155532 |
| 86 | MAP3K5 | 0.55847245 |
| 87 | ADRBK1 | 0.55259148 |
| 88 | OXSR1 | 0.52913719 |
| 89 | MATK | 0.52185175 |
| 90 | RPS6KA5 | 0.52007440 |
| 91 | CAMK4 | 0.51069459 |
| 92 | STK3 | 0.50343379 |
| 93 | SGK494 | 0.50275343 |
| 94 | SGK223 | 0.50275343 |
| 95 | EGFR | 0.48112799 |
| 96 | GRK1 | 0.46145135 |
| 97 | MAPK12 | 0.45912826 |
| 98 | PTK2B | 0.45411227 |
| 99 | FGR | 0.45322022 |
| 100 | PBK | 0.45206584 |
| 101 | PKN1 | 0.45083679 |
| 102 | BMX | 0.44428776 |
| 103 | MARK2 | 0.44187147 |
| 104 | TAOK2 | 0.43334635 |
| 105 | MAP2K6 | 0.42873649 |
| 106 | NME2 | 0.42359564 |
| 107 | PRKCD | 0.42292232 |
| 108 | MAP3K11 | 0.41953923 |
| 109 | SGK1 | 0.41046946 |
| 110 | RIPK1 | 0.40840946 |
| 111 | PDGFRB | 0.40299010 |
| 112 | RPS6KA6 | 0.39140538 |
| 113 | YES1 | 0.37856466 |
| 114 | CDK6 | 0.37752794 |
| 115 | STK38L | 0.37226834 |
| 116 | TNIK | 0.36996730 |
| 117 | PRKCH | 0.36684751 |
| 118 | CDK9 | 0.36011240 |
| 119 | FLT3 | 0.34647080 |
| 120 | IRAK2 | 0.31618900 |
| 121 | RPS6KA1 | 0.30785985 |
| 122 | INSR | 0.29295180 |
| 123 | MELK | 0.28827304 |
| 124 | MAP3K1 | 0.28649944 |
| 125 | BRD4 | 0.27773371 |
| 126 | ALK | 0.26506409 |
| 127 | TAOK1 | 0.24808285 |
| 128 | DMPK | 0.24802879 |
| 129 | HIPK2 | 0.24574096 |
| 130 | MAPK7 | 0.24244026 |
| 131 | IGF1R | 0.23997292 |
| 132 | GSK3A | 0.23966753 |
| 133 | MOS | 0.23480564 |
| 134 | CDK4 | 0.21093065 |
| 135 | PIK3CA | 0.20693504 |
| 136 | PDK1 | 0.20618482 |
| 137 | EIF2AK3 | 0.20417950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.52165605 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.37187163 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.14691506 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01611345 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.77071010 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.70638257 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54889691 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.45099071 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.40695866 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40147822 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.34963490 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24522354 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.21373717 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13554604 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.11523630 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05824934 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.01071682 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.00033293 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87575468 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.86160158 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78482694 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76045097 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.75060667 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.74364879 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.73283652 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71611069 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.67624371 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.67601613 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66286828 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.60846056 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54252768 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52633825 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49726761 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47524147 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45996618 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44759408 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.42605149 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38486581 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.26003281 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.23845286 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.20424721 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16956916 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10084699 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08898116 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06801787 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.01482352 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.01349103 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97032737 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95377037 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92444650 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87862486 |
| 52 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87121450 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82246979 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79945613 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76942590 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73912578 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73594247 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71895404 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71730226 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71231220 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67145035 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.61985664 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61164122 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.60828222 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.60657452 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58711502 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58512828 |
| 68 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56717574 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.55280733 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51034000 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50889192 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50280200 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50269948 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50058578 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49908432 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47906096 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47421079 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47115714 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.47069114 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47068481 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.46579452 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45838313 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44907037 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42963250 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41947698 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41908722 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41234685 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40338757 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39657880 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39408508 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36921620 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.36685831 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35915061 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35703024 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35638672 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35547020 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34574067 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33608916 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.33594093 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33542075 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33523907 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.33308174 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31998856 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31501557 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31498926 |
| 106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31480314 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30284178 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29825613 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29373336 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25152978 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25032809 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22857387 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21910568 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21488036 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21330210 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.20534063 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.19219226 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18299695 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16811578 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.16293647 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16236295 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12187158 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11033539 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09515066 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07892307 |

